![]() |
|||||||||||||||||
![]() |
|||||||||||||||||
![]() ![]() ![]() |
![]() |
|
|||||||||||||||
![]() |
![]() |
MATERIAL SAFETY DATA SHEET - INFECTIOUS SUBSTANCES SECTION I - INFECTIOUS AGENT NAME: Enterobacter spp. SYNONYM OR CROSS REFERENCE: E. aerogenes, , E. cloacae, E. gergoviae, ,E. amnigenus, E. asburiae, E. intermedius. E. hormaechei, E. cancerogenus, E. sakazkii, E. agglomeran (new genus Pantoea agglomerans) CHARACTERISTICS: Gram negative rods, peritrichous flagella, some encapsulated, facultatively anaerobic; family Enterobacteriaceae - 14 species SECTION II - HEALTH HAZARD PATHOGENICITY: Associated with a variety of infections including those of nosocomial origin; urinary, pulmonary, wound and bloodstream infections; often as a secondary or opportunistic infection EPIDEMIOLOGY: Worldwide; often associated with hospitals; nationwide epidemic of septicemia caused by contaminated IV products in 1971; increasingly recognized opportunistic pathogen in a wide variety of settings HOST RANGE: Humans INFECTIOUS DOSE: Not known MODE OF TRANSMISSION: Contact of mucous membranes with contaminated medical equipment and personnel; fecal-oral transmission INCUBATION PERIOD: Not clearly defined COMMUNICABILITY: As long as viable organisms are shed SECTION III - DISSEMINATION RESERVOIR: Soil, water, sewage, intestinal tract of humans and animals, dairy products ZOONOSIS: None VECTORS: None SECTION IV - VIABILITY DRUG SUSCEPTIBILITY: Sensitive to aminoglycosides, chloramphenicol, tetracyclines, TMP-SMX, nalidixic acid, nitrofurantoin DRUG RESISTANCE: Most strains of E. clocae and E. aerogenes are resistant to cephalothin; resistance to ampicillin SUSCEPTIBILITY TO DISINFECTANTS: Susceptible to many disinfectants - 1% sodium hypochlorite, 70% ethanol, 2% glutaraldehyde, iodines, phenolics, formaldehyde PHYSICAL INACTIVATION: Sensitive to moist heat (121° C for at least 15 min) and dry heat (160-170° C for at least 1 hour) SURVIVAL OUTSIDE HOST: Buttermilk - 10 days; cheese - 7-21 days; survives well in water-reservoirs of medical equipment (oxygenators, nebulizers, incubators etc.) SECTION V - MEDICAL SURVEILLANCE: Monitor for symptoms FIRST AID/TREATMENT: Antibiotic therapy as indicated IMMUNIZATION: None PROPHYLAXIS: Not usually administered SECTION VI - LABORATORY HAZARDS LABORATORY-ACQUIRED INFECTIONS: None reported to date SOURCES/SPECIMENS: Feces, urine, blood, wound exudates, sputum PRIMARY HAZARDS: Inhalation of infectious aerosols, direct contact of mucous membranes, accidental parenteral inoculation, ingestion SPECIAL HAZARDS: None SECTION VII - RECOMMENDED PRECAUTIONS CONTAINMENT REQUIREMENTS: Biosafety level 2 practices, facilities and containment equipment are recommended for all activities involving known or potentially contaminated clinical specimens and cultures of E. aerogenes PROTECTIVE CLOTHING: Laboratory coat; gloves when direct contact with infectious materials is unavoidable OTHER PRECAUTIONS: Good personal hygiene SECTION VIII - HANDLING INFORMATION SPILLS: Allow aerosols to settle; wearing protective clothing, gently cover spill with paper towels and apply 1% sodium hypochlorite, starting at perimeter and working towards the centre; allow sufficient contact time (30 min) before clean up DISPOSAL: Decontaminate before disposal; steam sterilization, chemical disinfection, incineration STORAGE: In sealed containers that are appropriately labelled SECTION IX - MISCELLANEOUS INFORMATION Date prepared: March, 2001 Prepared by: Office of Laboratory Security, PHAC Although the information, opinions and recommendations contained in this Material Safety Data Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date. Copyright © [Material Safety Data Sheets - Index]
|
![]() |
|||
![]() |
Last Updated: 2001-04-23 | ![]() |